Alzheimer's Drugs Show Promising Results

Posted: Updated:

WASHINGTON D.C. – The Alzheimer’s Association International Conference in Washington presented early results from two drug trials on Tuesday, July 22.

Both trials are only in early-mid stages. They have more than two years from finishing, but the first hints could mean they will result in a treatment in the future.

British researchers said the ground-breaking treatments offered a “sense of hope” in combating the life-shattering disease.

Another researcher points out there is still a long way to go.

Alzheimer’s research doctor Matthew Norton says the drug Solanezumab looks like it slows down the progression of loss of thinking and memory skills of people in very early stages of Alzheimer’s.

More trials are needed to measure if the drug will give a great effect over time. Another drug called Aducanumab from drug maker Bio Gen appears to remove the brain plaques associated with Alzheimer’s.

Current Conditions
  • Current Events